Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D002473:Cell Wall / Q000032:analysis*; D004187:Disaccharides / Q000032:analysis / Q000627:therapeutic use*; D006017:Glycolipids / Q000032:analysis / Q000627:therapeutic use*; D006168:Guinea Pigs; D007109:Immunity; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D009163:Mycobacterium bovis / Q000032:analysis*; D009171:Mycolic Acids / Q000032:analysis / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D010455:Peptides / Q000032:analysis / Q000627:therapeutic use*; D011134:Polysaccharides / Q000032:analysis / Q000627:therapeutic use*; D012882:Skin Tests; D014199:Trehalose / Q000032:analysis / Q000627:therapeutic use
D004187:Disaccharides; D006017:Glycolipids; D009171:Mycolic Acids; D010455:Peptides; D011134:Polysaccharides; D014199:Trehalose